LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jan 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-01-12

Reporting Person: RimAsia Capital Partners, L.P. (Director, 10% Owner)
Reporting Person: RimAsia Capital Partners GP, L.P. (Director, 10% Owner)
Reporting Person: RimAsia Capital Partners GP, Ltd. (Director, 10% Owner)
Reporting Person: Wei Eric (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-12	Common Stock, par value $0.001 per share	G	120000	—	Acquired	22529874	Direct

Footnotes

F1: On January 12, 2012, Eric H.C. Wei transferred 120,000 shares of common stock, par value $0.001 per share, of NeoStem, Inc. (the "Company"), owned directly by him to RimAsia Capital Partners, L.P. for no consideration.

F2: This Form 4 is filed jointly with (a) RimAsia Capital Partners GP, L.P., as the general partner of RimAsia Capital Partners, L.P., (b) RimAsia Capital Partners GP, Ltd., the general partner of RimAsia Capital Partners GP, L.P. and (c) Eric H.C. Wei, the sole director of RimAsia Capital Partners GP, Ltd. All such reporting persons have the address noted in Item 1.

F3: RimAsia Capital Partners GP, L.P., RimAsia Capital Partners GP, Ltd. and Eric H.C. Wei disclaim beneficial ownership of the securities held by RimAsia Capital Partners, L.P. except to the extent of any pecuniary interest therein, and the inclusion of these securities shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Securities Exchange Act or for any other purpose.